Poster Tour 2: Epidemiology & Public Health
Tracks
Track 3
Wednesday, September 11, 2019 |
3:30 PM - 4:00 PM |
Level 8 |
Speaker
Dr. Sofia Bartlett
Postdoctoral Fellow
BC Centre For Disease Control
#007 INCONSISTENCIES IN METHODOLOGY, REPORTING, AND SUBJECTIVE DESCRIPTION OF HEPATITIS C VIRUS REINFECTION RATES AMONG PEOPLE WHO INJECT DRUGS: POTENTIAL CONTRIBUTION TO STIGMA AND DISCRIMINATION?
3:30 PM - 3:35 PMBiography
Sofia Bartlett is a postdoctoral fellow at the BC Centre for Disease Control, working on the BC Hepatitis Testers Cohort. She is also a non-executive director of HepCBC Hepatitis Education and Prevention Society and adjunct associate lecturer at the Kirby Institute, UNSW Sydney.
Dr Karli Hochstatter
Research Scientist
University Of Wisconsin Madison
#011 DETECTING HEPATITIS C VIRUS TRANSMISSION CLUSTERS USING REMNANT SERUM SPECIMENS FROM KEY AFFECTED POPULATIONS TESTED IN PUBLIC HEALTH SETTINGS
3:40 PM - 3:45 PMBiography
Karli Hochstatter is a PhD candidate in Population Health Sciences at the University of Wisconsin School of Medicine and Public Health and a Research Assistant in the Department of Medicine. Her dissertation research focuses on the intersection of injection drug use, infectious diseases, and incarceration.
Ms Lara Marquez
PhD candidate
University of California San Diego
#014 What is the optimal HCV elimination strategy among PWID in a middle-income, high burden setting? A modeling and economic analysis in Tijuana, Mexico
3:45 PM - 3:50 PMBiography
Lara K Marquez is a PhD candidate in epidemiology at the University of California San Diego and San Diego State University. Her current research focuses on evaluating hepatitis C prevention and elimination strategies in key populations, specifically people who inject drugs and HIV-positive populations.
Ms Bridget Draper
Phd Candidate
Burnet Institute
#015 COMMUNITY-BASED POINT-OF-CARE TESTING AND TREATMENT FOR PEOPLE WHO INJECT DRUGS IN MYANMAR
3:50 PM - 3:55 PMBiography
Bridget Draper is a PhD Candidate at Burnet Institute/Monash University. Her project explores how to provide hepatitis C testing and treatment in resource-constrained settings using implementation science and health service delivery research methods. Previously Bridget worked as a Research Assistant on Eliminate Hepatitis C Partnership Project and the Prime Study.
Dr Olanrewaju Onigbogi
Phd Student
University of Eastern Finland
#018 WILLINGNESS TO ACCESS COMMUNITY-BASED HEPATITIS C AND HIV TESTING CENTRES AMONG INJECTING DRUG USERS IN LAGOS NIGERIA
3:55 PM - 4:00 PMBiography
Olanrewaju Onigbogi is a medical doctor with who is a member of the United Nations reference Group on HIV and Injecting Drug Use. He is currently undergoing a PhD program at the Department of Social and Health management at the University of Eastern Finland, Kuoipio, Finland.
Chair
Matthew Hickman
Professor in Public Health and Epidemiology
Professor in Public Health and Epidemiology